
Exploring the benefits of capturing and integrating molecular biomarker data within clinical trials to build foundations for data assets.
Exploring the benefits of capturing and integrating molecular biomarker data within clinical trials to build foundations for data assets.
As industry headlines buzz with drug pricing uncertainty and M&A speculation, sponsors can boost productivity on the R&D front through more conscious management of outsourcing spend.
Published: August 13th 2020 | Updated:
Published: August 1st 2017 | Updated: